The role of triple immunosuppressive treatment in the successful implantation of islet grafts.
Papalois
A
A
First Department of Propaedeutic Surgery, Hippocration Hospital, Athens, Greece.
Nikolaou
A
A
Nikolaou
C
C
Papalois
B
B
Tountas
C
C
Karamanos
V
V
Lykoudis
E
E
Davaris
P
P
Pataryas
T
T
Smyrniotis
V
V
Papadimitriou
L
L
Golematis
B
B
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000601:surgery*; D004359:Drug Therapy, Combination; D005951:Glucose Tolerance Test; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology* / Q000502:physiology; D011239:Prednisolone / Q000627:therapeutic use; D013552:Swine; D014184:Transplantation, Homologous
D001786:Blood Glucose; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001379:Azathioprine